28
Views
54
CrossRef citations to date
0
Altmetric
Original Article

Session 6: Is Hypergastrinaemia Dangerous to Man?

&
Pages 179-191 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

R. Arnold, M. Frank, B. Simon, R. Eissele & H. Koop. (1992) Adaptation and Renewal of the Endocrine Stomach. Scandinavian Journal of Gastroenterology 27:sup193, pages 20-27.
Read now
H. F. Helander, K. Rutgersson, K. G. Helander, J. P. Pisegna, J. D Gardner, R. T. Jensen & P. N. Maton. (1992) Stereologic Investigations of Human Gastric Mucosa: II. Oxyntic Mucosa from Patients with Zollinger-Ellison Syndrome. Scandinavian Journal of Gastroenterology 27:10, pages 875-883.
Read now
N. Havu, H A. Maaroos & P. Sipponen. (1991) Argyrophil Cell Hyperplasia Associated with Chronic Corpus Gastritis in Gastric Ulcer Disease. Scandinavian Journal of Gastroenterology 26:sup186, pages 90-94.
Read now

Articles from other publishers (51)

Luiz Gonzaga Vaz COELHO & Maria Clara Freitas COELHO. (2021) Helicobacter pylori and colorectal neoplasms: a concise review. Arquivos de Gastroenterologia 58:1, pages 114-119.
Crossref
Prabhakar Singh, Shree Prakash Tiwari, Mohammad Murtaza Mehdi & Rajesh Sharma. 2021. Colon Cancer Diagnosis and Therapy. Colon Cancer Diagnosis and Therapy 109 142 .
Stefano C. Previtali, Teresa Gidaro, Jordi Díaz-Manera, Alberto Zambon, Stephanie Carnesecchi, Pascale Roux-Lombard, Pietro Spitali, Mirko Signorelli, Cristina Al-Khalili Szigyarto, Camilla Johansson, Julian Gray, Delphine Labolle, Florence Porte Thomé, Jacqueline Pitchforth, Joana Domingos & Francesco Muntoni. (2020) Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy. Pharmacological Research 159, pages 104999.
Crossref
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito & Robert T. Jensen. (2019) Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences 20:20, pages 5128.
Crossref
Gwen Murphy, Christian C Abnet, Hyoyoung Choo-Wosoba, Emily Vogtmann, Stephanie J Weinstein, Philip R Taylor, Satu Männistö, Demetrius Albanes, Sanford M Dawsey, Jens F Rehfeld & Neal D Freedman. (2017) Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers. International Journal of Epidemiology 46:3, pages 914-923.
Crossref
QU Baoge. (2017) Influence of Long-Term Use of Proton Pump Inhibitors on Esophageal and Gastrointestinal Precancerous Lesions or Carcinoma. Archives of Clinical Gastroenterology, pages 029-032.
Crossref
Thomas G K Breuer, Laura Borker, Daniel R Quast, Andrea Tannapfel, Wolfgang E Schmidt, Waldemar Uhl & Juris J Meier. (2016) Impact of proton pump inhibitor treatment on pancreatic beta-cell area and beta-cell proliferation in humans. European Journal of Endocrinology 175:5, pages 467-476.
Crossref
G. R. Betton. (2013) A review of the toxicology and pathology of the gastrointestinal tract. Cell Biology and Toxicology 29:5, pages 321-338.
Crossref
IV Kompanets'OH Korotkyĭ, VV Nikols'ka, LI Ostapchenko & SV Pylypenko. (2013) The interferon production by rat spleen and thymus lymphocytes in condititons of hypoacidity. Fiziolohichnyĭ zhurnal 59:1, pages 84-88.
Crossref
Edith Lahner, Andrea Sbrozzi-Vanni, Lucy Vannella, Vito Domenico Corleto, Emilio Di Giulio, Gianfranco Delle Fave & Bruno Annibale. (2012) No higher risk for colorectal cancer in atrophic gastritis-related hypergastrinemia. Digestive and Liver Disease 44:9, pages 793-797.
Crossref
M. SINGH, G. DHINDSA, S. FRIEDLAND & G. TRIADAFILOPOULOS. (2007) Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas. Alimentary Pharmacology & Therapeutics 26:7, pages 1051-1061.
Crossref
J. Ferrándiz-Santos & J. Alvarez-Duque. (2006) Manejo clínico de la enfermedad por reflujo gastroesofágico. FMC - Formación Médica Continuada en Atención Primaria 13:4, pages 217-229.
Crossref
Robert T. Jensen. (2006) Consequences of Long-Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 98:1, pages 4-19.
Crossref
Mercedes Domínguez Antonaya, Diego Moreno Sánchez & Raquel González Alonso. (2004) Estrategias terapéuticas en la enfermedad por reflujo gastroesofágico no erosiva. Medicina Clínica 123:9, pages 352-356.
Crossref
Irvin M Modlin, Kevin D Lye & Mark Kidd. (2004) A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?. American Journal of Gastroenterology 99:1, pages 23-32.
Crossref
Robert M Genta, Guido Rindi, Roberto Fiocca, David J Magner, Donald D'Amico & Douglas S Levine. (2003) Effects of 6–12 Months of Esomeprazole Treatment on The Gastric Mucosa. American Journal of Gastroenterology 98:6, pages 1257-1265.
Crossref
E Crocetti & E Paci. (2003) Malignant carcinoids in the USA, SEER 1992–1999. An epidemiological study with 6830 cases. European Journal of Cancer Prevention 12:3, pages 191-194.
Crossref
Irvin M. Modlin, Kevin D. Lye & Mark Kidd. (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97:4, pages 934-959.
Crossref
Robert T. Jensen. (2003) Involvement of Cholecystokinin/Gastrin‐Related Peptides and their Receptors in Clinical Gastrointestinal Disorders. Pharmacology & Toxicology 91:6, pages 333-350.
Crossref
Michael Torbenson, Susan C Abraham, John Boitnott, John H Yardley & Tsung-Teh Wu. (2002) Autoimmune Gastritis: Distinct Histological and Immunohistochemical Findings Before Complete Loss of Oxyntic Glands. Modern Pathology 15:2, pages 102-109.
Crossref
S. Sanduleanu, D. Jonkers, A. de Bruïne, W. Hameeteman & R.W. Stockbrügger. (2001) Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. Digestive and Liver Disease 33:8, pages 707-719.
Crossref
M. Naunton, G. M. Peterson & M. D. Bleasel. (2008) Overuse of proton pump inhibitors. Journal of Clinical Pharmacy and Therapeutics 25:5, pages 333-340.
Crossref
M. Naunton, G. M. Peterson & M. D. Bleasel. (2000) Overuse of proton pump inhibitors. Journal of Clinical Pharmacy and Therapeutics 25:5, pages 333-340.
Crossref
Laine, Ahnen, Mcclain, Solcia & Walsh. (2001) Review article: potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors. Alimentary Pharmacology & Therapeutics 14:6, pages 651-668.
Crossref
I. GRITTI, G. BANFI & G.S. ROI. (2000) PEPSINOGENS: PHYSIOLOGY, PHARMACOLOGY PATHOPHYSIOLOGY AND EXERCISE. Pharmacological Research 41:3, pages 265-281.
Crossref
Robinson. (1999) Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia. Alimentary Pharmacology & Therapeutics 13, pages 5-10.
Crossref
Werner Creutzfeldt. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors 91 115 .
Yan-Shi Guo & Courtney M . TownsendJr.Jr.. 1999. Gastrointestinal Endocrinology. Gastrointestinal Endocrinology 189 214 .
Christine M. Thorburn*Gary D. Friedman‡Chris J. Dickinson§Joseph H. Vogelman∥, Norman Orentreich∥ & Julie Parsonnet*,#. (1998) Gastrin and colorectal cancer: A prospective study. Gastroenterology 115:2, pages 275-280.
Crossref
Schenk, Kuipers, Klinkenberg-Knol, Bloemena, Nelis, Festen, Jansen, Biemond, Lamers & Meuwissen. (1998) Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection . Alimentary Pharmacology & Therapeutics 12:7, pages 605-612.
Crossref
Heidi‐Ingrid MaaroosNiilo HavuPentti Sipponen. (2001) Follow‐Up of Helicobacter pylori Positive Gastritis and Argyrophil Cells Pattern During the Natural Course of Gastric Ulcer . Helicobacter 3:1, pages 39-44.
Crossref
Irvin M. Modlin & Andras Sandor. (2000) An analysis of 8305 cases of carcinoid tumors. Cancer 79:4, pages 813-829.
Crossref
Martin Tobi, Annemieke Cats, Benedict J. Maliakkal, Joseph L. Kinzie, Roy Maliakkal, Robin P. F. Dullaart & Gordon D. Luk. (1997) Zollinger-Ellison Syndrome, Acromegaly, and Colorectal Neoplasia. Journal of Clinical Gastroenterology 24:1, pages 21-24.
Crossref
H. Koop. 1997. Gastrointestinale Funktionsstörungen. Gastrointestinale Funktionsstörungen 693 702 .
JANICE L. PODOLSKI. (1996) Recent Advances in Peptic Ulcer Disease: Helicobacter Pylori Infection and Its Treatment. Gastroenterology Nursing 19:4, pages 128-136.
Crossref
Martin Tobi, Sreenivas Chintalapani, Robert Goo, Benedict Maliakkal, Jyothi Reddy, Monalill Lundqvist, Kjell Öberg & Gordon Luk. (1995) Omeprazole inhibits growth of cancer cell line of colonic origin. Digestive Diseases and Sciences 40:7, pages 1526-1530.
Crossref
J. M. KIMMIG. (2007) Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies. Alimentary Pharmacology & Therapeutics 9:3, pages 281-286.
Crossref
Jens F. Rehfeld. (1995) Gastrin and colorectal cancer: A never-ending dispute?. Gastroenterology 108:4, pages 1307-1310.
Crossref
David M. Pinson, Niilo Havu, Mario I. Sztern, Hillevi Mattsson, Greg A. Looney, Bruce F. Kimler & Aryeh Hurwitz. (1995) Drug-induced hypergastrinemia: Absence of trophic effects on colonic carcinoma in rats. Gastroenterology 108:4, pages 1068-1074.
Crossref
R. F. McCloy, R. Arnold, K. D. Bardhan, D. Cattan, E. Klinkenberg-Knol, P. N. Maton, R. H. Riddell, P. Sipponen & A. Walan. (1995) Pathophysiological effects of long-term acid suppression in man. Digestive Diseases and Sciences 40:S2, pages 96S-120S.
Crossref
James W. Freston, Kurt Borch, Stephen J. Brand, Enar Carlsson, W. Creutzfeldt, Rolf Håkanson, Lars Olbe, Enrico Solcia, John H. Walsh & M. Michael Wolfe. (1995) Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. Digestive Diseases and Sciences 40:S2, pages 50S-62S.
Crossref
W. A. De BOER & G. N. J. TYTGAT. (2007) Review article: drug therapy for reflux oesophagitis. Alimentary Pharmacology & Therapeutics 8:2, pages 147-157.
Crossref
Andreas W. Herling & Klaus Weidmann. 1994. 233 264 .
R. Lamberts. 1994. Ökosystem Darm VI. Ökosystem Darm VI 277 286 .
Cesare Bordi, Cinzia Azzoni, Francesco P. Pilato, Flavio Robutti, Giancarlo D'Ambra, Pietro Caruana, Guido Rindi, Vito D. Corleto, Bruno Annibale & Gianfranco Delle Fave. (1993) Morphometry of gastric endocrine cells in hypergastrinemic patients treated with the somatostatin analogue octreotide. Regulatory Peptides 47:3, pages 307-318.
Crossref
Regina Lamberts, Werner Creutzfeldt, Hans G. Strüber, Gorik Brunner & Enrico Solcia. (1993) Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis. Gastroenterology 104:5, pages 1356-1370.
Crossref
Herbert Koop, Margareta Frank, Simone Kuly, R�diger Nold, Rolf Eissele, Gudrun Rager, Josef R�schoff, Matthias Rothmund & Rudolf Arnold. (1993) Gastric argyrophil (enterochromaffin-like), gastrin, and somatostatin cells after proximal selective vagotomy in man. Digestive Diseases and Sciences 38:2, pages 295-302.
Crossref
Kenneth R. McQuaid & Jon I. Isenberg. (1992) Medical Therapy of Peptic Ulcer Disease. Surgical Clinics of North America 72:2, pages 285-316.
Crossref
K. G. Wormsley. (2007) OMEPRAZOLE. Alimentary Pharmacology & Therapeutics 5:6, pages 670-673.
Crossref
Roger G. Berlin. (1991) Omeprazole: Gastrin and gastric data (August 1991). Digestive Diseases and Sciences 36:10, pages 1501-1502.
Crossref
K. G. Wormsley. (1991) Omeprazole: Gastrin and gastric data. Digestive Diseases and Sciences 36:8, pages 1173-1175.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.